Interleukin-13 effects on activated monocytes lead to novel cytokine secretion profiles intermediate between those induced by interleukin-10 and by interferon-γ

European Cytokine Network

Volumn 8, Issue 2, 1997, Pages 189-201

  Minty, Adrian ^a   Ferrara, Pascual ^a   Caput, Daniel ^a  

^a SANOFI   (France)

Author keywords

IFN ; IL 10; IL 12; IL 13; Inflammatory cytokine production; Monocyte

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOKINE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATION; MONOCYTE;

EID: 0031412633     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cherwinski H M, Schumacher J H, Brown K D, Mosmann T R. 1987. Two types of mouse helper T-cell clone III. Further Differences in Lymphokine Synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166: 1229.
2. Dolganov G, Bort S, Lovett M, Burr J, Schubert L, Short D, McGurn M, Gibson C, Lewis D B. 1996. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87: 3316.
3. Minty A, Chalon P, Derocq J M, Dumont X, Guillemot J C, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248.
4. Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovuni A, Colotta F. 1994. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 83: 1738.
5. Colotta F, Re F, Muzio M, Polentarutti N, Minty A, Caput D, Ferrara P, Mantovani A. 1994. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 269: 12403.
6. Endo T, Ogushi F, Sone S. 1996. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma. J. Immunol. 156: 2240.
7. Nassar G M, Morrow J D, Roberts L J 2d, Lakkis F G, Badr K F. 1994. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 269: 27631.
8. Deleuran B, Iversen L, Deleuran M, Yssel H, Kragballe K, Stengaard-Pedersen K, Thestrup-Pedersen K. 1995. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMO A comparison between IL-4 and IL-13. Cytokine 7: 319.
9. Cosentino G, Soprana E, Thienes C P, Siccardi A G, Viale G, Vercelli D. 1995. IL-13 down-regulates CD14 expression and TNF-α secretion in normal human monocytes. J. Immunol. 155: 3145.
10. Doherty T M, Kastelein R, Menon S, Andrade S, Coffman R L. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151: 7151.
11. Doyle A G, Herbein G, Montaner L J, Minty A J, Caput D, Ferrara P, Gordon S. 1994. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur. J. Immunol. 24: 1441.
12. Sozzani P, Cambon C, Vita N, Séguelas M H, Caput D, Ferrara P, Pipy B. 1995. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. Role of calcium and cyclic AMP. J. Biol. Chem. 270: 5084.
13. Cash E, Minty A, Ferrara P, Caput D, Rott O. 1994. Macrophage-inactivating interleukin-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol. 153: 4258.
14. Bessis N, Boissier M C, Ferrara P, Blankenstein T, Fradelizi D, Fournier C. 1996. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26: 2399.
15. Sironi M, Sciacca F L, Matteucci C, Conni M, Vecchi A, Bernasconi S, Minty A, Caput D, Ferrara P, Colotta F, Mantovani A. 1994. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84: 1913.
16. Derocq J M, Segui M, Poinot-Chazel C, Minty A, Caput D, Ferraru P, Casellas P. 1994. Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4. FEBS Lett. 343: 32.
17. Kolios G, Robertson D A, Jordan N J, Minty A, Caput D, Ferrara P, Westwick J. 1996. Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13. Br. J. Pharmacol. 119: 351.
18. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor a production. J. Exp. Med. 181: 537.
19. Kambayashi T, Jacob C O, Strassmann G. 1996. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell. Immunol. 171: 153.
20. Flesch I E, Hess J H, Huang S, Aguet M, Rothe J, Bluethmann H, Kaufmann S H. 1995. Early inlerleukin 12 production by macrophages in response to mycobacterial infection depends on interferon-γ and tumor necrosis factor-α. J. Exp. Med. 181: 1615.
21. Hart P H, Ahern M J, Smith M D, Finlay-Jones J J. 1995. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin. Exp. Immunol. 99: 331.
22. Kucharzik T, Lugering N, Weigelt H, Adolf M, Domschke W, Stoll R. 1996. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease: comparison with IL-4 and IL-10. Clin. Exp. Immunol. 104: 483.
23. de Waal Malefyt R, Figdor C G, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries J E. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J. Immunol. 151: 6370.
24. Ferrara P, Pecceu F, Marchese E, Vita N, Roskam W, Lupker J. 1987. Characterization of recombinant glycosylated human interleukin-2 produced by a recombinant plasmid transformed CHO cell line. FEBS Lett. 226: 47.
25. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
26. Dinarello C A. 1991. Interleukin-1 and interleukin-1 antagonism. (Review) Blood 77: 1627.
27. Hayes M P, Wang J, Norcross M A. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86: 646.
28. Kubin M, Chow J M, Trinchieri G. 1994. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor-α and IL-1β production in human myeloid cell lines and peripheral blood mononuclear cells. Blood 83: 1847.
29. de Waal Malefyt R, Abrams J, Bennett B, Figdor C G, de Vries J E. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209.
30. Chomarat P, Rissoan M C, Banchereau J, Miossec P. 1993. Interferon-γ inhibits interleukin-10 production by monocytes. J. Exp. Med. 177: 523.
31. van der Pouw Kraan T C, Boeije L C, Smeenk R J, Wijdenes J, Aarden L A. 1995. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med. 181: 775.
32. Hart P H, Vitti G F, Burgess D R, Whitty G A, Piccoli D S, Hamilton J A. 1989. Potential anti-inflammatory effects of interleukin-4: suppression of human monocyte tumor necrosis factor-α, interleukin-1, and prostaglandin E2. Proc. Natl. Acad. USA 86: 3803.
33. Trinchieri G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type1 and cytotoxic lymphocytes. (Review) Blood 84: 4008.
34. Blauer F, Groscurth P, Schneemann M, Schoedon G, Schaffner A. 1995. Modulation of the antilisterial activity of human blood-derived macrophages by activating and deactivating cytokines. J. Interferon Cyrokine Res. 15: 105.
35. Geng Y, Zhang B, Lotz M. 1993. Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol. 151: 6692.
36. Kohler I, Alliger P, Minty A, Caput D, Ferrara P, Holl-Neugebauer B, Rank G, Rieber E P. 1994. Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL4 sharing a DNA binding motif with an interferon-γ-induced nuclear binding factor. FEBS Lett. 345: 187.
37. Lehmann J, Seegert D, Strehlow I, Schindler C, Lohmann-Matthes M L, Decker T. 1994. IL-10 induced factors belonging to the p91 family of proteins bind to IFN-γ-responsive promoter elements. J. Immunol. 153: 165.
38. Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R, Weber-Nordt R M. 1996. IL-10 induces DNA binding activity of three STAT proteins (STAT-1, STAT-3, STAT-5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394: 365.
39. Zurawski G, de Vries J E. 1994. Interleukin-13. an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. (Review) Immunol. Today 15: 19.
40. Snijders A, Hilkens C M, van der Pouw Kraan T C, Engel M, Aarden L A, Kapsenberg M L. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156: 1207.
41. Gillessen S, Carvajal D, Ling P, Podlask F J, Stremlo D L, Familletti P C, Gubler U, Presky D H, Stern A S, Gately M K. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25: 200.
42. Skeen M J, Miller M A, Shinnick T M, Ziegler H K. 1996. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156: 1196.
43. Murphy T L, Cleveland M G, Kulesza P, Magram J, Murphy K M. 1995. Regulation of interleukin-12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15: 5258.
44. Tripp C S, Wolf S F, Unanue E R. 1993. Interleukin-12 and tumor necrosis factor-α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis. and interleukin-10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90: 3725.
45. Flynn J L, Goldstein M M, Chan J, Triebold K J, Pfeffer K, Lowenstein C J, Schreiber R, Mak T W, Bloom B R. 1995. Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity 2:561.
46. Chehimi J, Starr S E, Franck I, d'Andrea A, Ma X, Mac Gregor R R, Sennelier J, Trinchieri G. 1994. Impaired interleukin-12 production in immunodeficiency virus-infected patients. J. Exp. Med. 179: 1361.
47. Karp C L, Wysocka M, Wahl L M, Ahearn J M, Cuomo P J, Sherry B, Trinchieri G, Griffin D E. 1996. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273: 228.
48. Frucht D M, Holland S M. 1996. Detective monocyte costimulation for IFN-γ production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J. Immunol. 157: 411.
49. Tang Y W, Graham B S. 1994. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J. Clin. Invest. 94: 1953.
50. Kopf M, Le Gros G, Bachmann M, Lamers M C, Bluethmann H, Kohler G. 1993. Disruption of the murine IL-4 gene blocks TH-2 cytokine responses. Nature 362: 245.
51. Leal L M, Moss D W, Kuhn R, Muller W, Liew F W. 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23: 566.
52. + T-cells. analysed at the single cell level. J. Exp. Med. 184: 473.
53. Kaplan M H, Schindler U, Smiley S T, Grusby M J. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4: 313.
54. Paul W E, Seder R A. 1994. Lymphocyte responses and cytokines. (Review) Cell 76: 241.
55. Germann T, Gately M K, Schoenhaut D S, Lohoff M, Mattner F, Fischer S, Jin S C, Schmitt E, Rude E. 1993. Interleukin-12/T-cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 23: 1762.
56. McArthur J G, Raulet D H. 1993. CD-28 induced co-stimulation of T helper type 2 cells mediated by induction of responsiveness to interleukin-4. J. Exp. Med. 178: 1645.
57. Wynn T A, Jankovic D, Hieny S, Zioncheck K, Jardieu P, Cheever A W, Sher A. 1995. IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-γ. J. Immunol. 154: 3999.
58. + T-cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547.
59. D'Andrea A, Aste-Amezaga M, Valiante N M, Ma X, Kubin M, Trinchieri G. 1993. Interleukin-10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041.
60. + T-cells: modulation by interleukin-4 and interleukin-12. Eur. J. Immunol. 26: 571.
61. van der Pouw Kraan T C, Boeije L C, Troon J T, Rutschmann S K, Wijdenes J, Aarden L A. 1996. Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL13 production by cyclosporin A. J. Immunol. 156: 1818.